Newsroom

Recent News Releases

September 18, 2020 9/18/2020

Takeda Presents New Data Highlighting Scientific Advancements in Lung Cancer

at ESMO Virtual Congress

September 16, 2020 9/16/2020

Takeda to Divest TachoSil^® to Corza Health for €350 Million

September 15, 2020 9/15/2020

Takeda Opens New R&D Cell Therapy Manufacturing Facility to Support Expansion of Next-Generation Clinical Programs

September 9, 2020 9/9/2020

Takeda Announces Results from Phase 3 Clinical Trial Evaluating NINLARO™ (ixazomib) in Newly Diagnosed Multiple Myeloma

September 8, 2020 9/8/2020

Takeda Divests Select Non-Core Assets in Europe to Cheplapharm for Approximately $562 million USD

SEE ALL NEWS AND RELEASES >

・For Shire news releases, click here

Featured Topics

Understanding the Role of Orexin in Sleep and Wakefulness

Learn more

Exploring New Paths in Narcolepsy

Learn more

Spotlight Malawi: Many Paths Towards Universal Health Coverage and a Strong Health Workforce

Learn more

Guided by Our Values: Supporting Global COVID-19 Response

Learn more

A ‘Swiss Cheese’ Approach Can Give Us a Second Chance to Contain COVID-19

Learn more

SEE ALL FEATURED TOPICS ARTICLES >

In the News

With this new original series featured in Asahi Shimbun Globe, President & CEO Christophe Weber gives his unique perspective on what he has learned from his upbringing in France and his international career.

LEARN MORE

Executive Leadership

Meet our Executive Leadership Team led by our President and CEO, Christophe Weber

LEARN MORE

For media inquiries or reporter requests for more information, contact our Corporate Communications via Media_Relations@takeda.com. If you generally would like to contact us, please visit Contact Us.